Navigation Links
Study: Latent Viruses Change Cells in the Human Body; the Study Supports the Link between Latent Viruses and Disease
Date:12/8/2013

Rochester, NY (PRWEB) December 08, 2013

The CBCD believes that those scientists, who view latent viruses as harmless, are wrong. One can find an example of such a view in a study published as recent as 2012 in the journal of Medical Microbiology and Immunology. Researchers wrote that the Human Cytomegalovirus (CMV), “stays for the lifetime of the host in a non-infectious, replicatively dormant state known as 'viral latency' (2).” Notice that the researchers equate ‘dormancy’ with ‘latency.’ Even the CDC considers the two as one and the same. On its website published on May 16. 2006, the CDC stated that “EBV remains dormant or latent in a few cells…” (2). Note that the website uses the word ‘or’, meaning according to the CDC, ‘dormant’ and ‘latent’ are interchangeable.

This is a misconception.

There is much research, which shows that latent viruses are not dormant. In fact, as a new study found, “…advances in techniques to study global changes in gene expression have begun to show that HCMV latency is a highly active process which involves expression of specific latency-associated viral gene products which orchestrate major changes in the latently infected cell (1).” In addition, “as techniques for studying HCMV at a molecular level have become increasingly powerful, it is now emerging that latent HCMV infection profoundly modulates the latently infected cell and the surrounding cellular environment (1).”

In particular, researchers wrote that all of the herpes viruses, which are responsible for much of the viral disease burden in humans, affect the body while latent. Research shows the existence of “a common unifying theme in the biology of herpesvirus latency and reactivation (1).”

Thus, all herpes viruses, including the Human Cytomegalovirus (CMV), oral herpes (HSV-1), genital herpes (HSV-2), and the Epstein Barr Virus (EBV), have a similar impact on the body, specifically during latency. They all replicate, and express proteins.

Another study showed that human ganglia (a mass of nerve cells), which were infected with the latent Varicella Zoster Virus, showed multiple VZV transcripts. “RT-PCR and in situ hybridization studies have identified multiple VZV transcripts in latently infected human ganglia. State-of-the-art multiplex PCR technology, capable of detecting all 68 annotated VZV gene transcripts, revealed transcription of at least 12 VZV genes during latency…(3).” This is according to a study published on September 14, 2013 in the journal, Viruses.

“We believe that doctors need to take the time to read the latest research on viral latency. Latent viruses are active, and can be dangerous. One great source of information on this subject is “Microcompetition with Foreign DNA and the Origin of Chronic Disease,” a book by Dr. Hanan Polansky, which includes an explanation on how latent viruses cause most major diseases.” – Greg Bennett, CBCD

The following is a simplified explanation of that theory. Dr. Hanan Polansky discovered that foreign DNA fragments, called N-boxes, cause most major diseases. When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent or the viral DNA is broken into pieces and cannot express proteins.

To learn more about Dr. Hanan Polansky’s research and the Theory of Microcompetition with Foreign DNA, visit: http://www.cbcd.net

References:

(1)    Human Cytomegalovirus Manipulation of Latently Infected Cells. Published on November 21, 2013.
        http://www.mdpi.com/1999-4915/5/11/2803

(2)    Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection. Published in November, 2012.
             http://www.ncbi.nlm.nih.gov/pubmed/22991040

(3)    Varicella zoster virus (VZV)-human neuron interaction. Published on September 4, 2013.
         http://www.ncbi.nlm.nih.gov/pubmed/24008377

The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11402965.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
2. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
3. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
4. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
5. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
6. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
7. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
8. Nature Materials study: Boosting heat transfer with nanoglue
9. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
10. Nature Materials study: Graphene invisible to water
11. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Information Management Services ( ... The upgrade represents a completely new technical foundation and is so significant it ... responsive design interface, significantly increased speed for search results, a streamlined layout and a ...
(Date:2/8/2016)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new website has gone live. On Thursday, ... mobile-friendly. Visit the new site: www.diplomat.is ... ... ... "The goal was to reimagine the website and create ...
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical industry ... a host of launch activities including the identification and ... launch activity is especially high in the oncology therapeutic ... Best Practices and the Role of Medical Affairs in ... focused on oncology therapies find better ways to utilize ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):